Category: C.R. BardSyndicate content

Boston Scientific, Bard CEOs cool on consolidation

October 23, 2014 by Brad Perriello

The CEOs of medical device companies Boston Scientific and C.R. Bard are cool on the consolidation trend in medtech, saying they don't see the need for mega-deals to grow their businesses.

Boston Scientific, Bard CEOs cool on consolidation

Bard shares gain on nearly 50% earnings rise

October 23, 2014 by Brad Perriello

C.R. Bard reports a 3rd-quarter earnings gain of nearly 50% and raises its guidance for the rest of the year, sending share prices up this morning on Wall Street.

Bard shares gain on nearly 50% earnings rise

C.R. Bard (NYSE:BCR) shares are up more than 3% this morning on Wall Street after the medical device company reported that its 3rd-quarter earnings rose 47.0% compared with the same period last year.

Supreme Court declines to hear appeal by Mirowski Family Ventures | Medtech legal news for the week of October 20, 2014

October 20, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Supreme Court passes on Mirowski-Medtronic patent case; Medtronic can't shake shareholders lawsuit over Infuse; FDA strikes out again in Prevor drug-or-device case; Ex-Bard, BD engineer gets 18 months for stealing trade secrets; Appeals court: Fujifilm Medical executive wasn't fired for not being Japanese

Supreme Court passes on Mirowski-Medtronic patent case

October 15, 2014 by Val Kennedy

Ex-Bard, BD engineer gets 18 months for stealing trade secrets

October 17, 2014 by Brad Perriello

A former engineer for Becton, Dickinson & Co. and C.R. Bard who confessed to stealing trade secrets concerning an injector pen is sentenced to 18 months in prison.

Ex-Bard, BD engineer gets 18 months for stealing trade secrets

3rd FDA panel barely favors BSX's Watchman | Regulatory news for the week of October 13, 2014

October 14, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: 3rd FDA panel vote barely favors Boston Scientific's Watchman anti-stroke device; Medtronic launches Verify incontinence device in the U.S.; FDA OKs Integra Lifesciences Puerto Rico plant; FDA approves Bard's Lutonix DEB

UPDATE: 3rd FDA panel vote barely favors Boston Scientific's Watchman anti-stroke device

October 9, 2014 by Brad Perriello

Medtronic shareholder sues over company's plan to cover nearly $58M in taxes | Medtech legal news for the week of October 13, 2014

October 13, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Shareholder sues Medtronic over plan to cover execs' $58m tax tab; Report: Bard's mesh settlement is worth $21m; Covidien's Ev3 logs a pair of legal wins over Appriva, whistleblower; BD loses bid to overturn $114m antitrust loss to Retractable Technologies; Ex-Oriole DeCinces fights insider trading charges

Shareholder sues Medtronic over plan to cover execs' $58m tax tab

October 7, 2014 by Brad Perriello

FDA approves Bard's Lutonix DEB

October 10, 2014 by Brad Perriello

The FDA grants pre-market approval for C.R. Bard's Lutonix drug-eluting balloon for treating peripheral artery disease.

FDA approves Bard's Lutonix DEB

C.R. Bard (NYSE:BCR) said today that the FDA granted pre-market approval for its Lutonix drug-eluting balloon for treating peripheral artery disease, well ahead of the company's expectation for approval early next year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp